These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 17288689)

  • 1. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
    Mildvan D; Creagh T; Leitz G;
    Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia and its treatment and outcomes in persons infected with human immunodeficiency virus.
    Buskin SE; Sullivan PS
    Transfusion; 2004 Jun; 44(6):826-32. PubMed ID: 15157246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
    Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
    Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia prevalence and associated risk factors in a single-center ambulatory HIV clinical cohort.
    Wills TS; Nadler JP; Somboonwit C; Vincent A; Leitz G; Marino K; Naik E; Powers S; Khan N; Laartz B
    AIDS Read; 2004 Jun; 14(6):305-10, 313-5. PubMed ID: 15243966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaemia during pregnancy in Burkina Faso, west Africa, 1995-96: prevalence and associated factors. DITRAME Study Group.
    Meda N; Mandelbrot L; Cartoux M; Dao B; Ouangré A; Dabis F
    Bull World Health Organ; 1999; 77(11):916-22. PubMed ID: 10612887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women.
    Floris-Moore M; Howard AA; Lo Y; Arnsten JH; Santoro N; Schoenbaum EE
    HIV Med; 2006 Oct; 7(7):421-30. PubMed ID: 16925727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.
    Tappuni AR; Fleming GJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):623-8. PubMed ID: 11740479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy.
    Curkendall SM; Richardson JT; Emons MF; Fisher AE; Everhard F
    HIV Med; 2007 Nov; 8(8):483-90. PubMed ID: 17944680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model.
    Chu H; Gange SJ; Yamashita TE; Hoover DR; Chmiel JS; Margolick JB; Jacobson LP
    Am J Epidemiol; 2005 Oct; 162(8):787-97. PubMed ID: 16135508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemoglobin and albumin as markers of HIV disease progression in the highly active antiretroviral therapy era: relationships with gender.
    Shah S; Smith CJ; Lampe F; Youle M; Johnson MA; Phillips AN; Sabin CA
    HIV Med; 2007 Jan; 8(1):38-45. PubMed ID: 17305931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
    Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
    Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients.
    Bonnet F; Pineau JJ; Taupin JL; Feyler A; Bonarek M; de Witte S; Bernard N; Lacoste D; Morlat P; Beylot J
    J Rheumatol; 2003 Sep; 30(9):2005-10. PubMed ID: 12966606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine.
    Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Saekang N; Pairoj W; Chantratita W
    J Clin Virol; 2008 Apr; 41(4):310-3. PubMed ID: 18316243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?
    Newell ML; Patel D; Goetghebuer T; Thorne C;
    J Infect Dis; 2006 Apr; 193(7):954-62. PubMed ID: 16518757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.
    Napravnik S; Keys JR; Quinlivan EB; Wohl DA; Mikeal OV; Eron JJ
    AIDS; 2007 Apr; 21(7):825-34. PubMed ID: 17415037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of zidovudine induced anaemia in HIV infected patients in eastern India.
    Agarwal D; Chakravarty J; Chaube L; Rai M; Agrawal NR; Sundar S
    Indian J Med Res; 2010 Oct; 132():386-9. PubMed ID: 20966515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.